Nonsurgical Treatment of Severe Hypertension Due to Renal-Artery Intimal Fibroplasia by Percutaneous Transluminal Angioplasty

Authors:
  • VMVictor G. Millan
    Victor G. Millan
  • WMWilliam E. Mast
    William E. Mast
  • NMNicolaos E. Madias
    Nicolaos E. Madias

Abstract
RENAL vascular surgery and pharmacotherapy are the are the two modalities currently employed, singly or in combination, in the management of renovascular hypertension.1 2 3 Although both methods have been used successfully in the treatment of this disorder, both have substantial drawbacks. Renovascular operations carry a consequential operative risk, have a substantial failure rate and are expensive.1 2 3 4 5 6 Furthermore, the suitability of this method of treating renovascular disease is clearly limited by the usually progressive and frequently bilateral nature of the dis-, order.1 , 2 On the other hand, pharmacotherapy of renovascular hypertension has such disadvantages as poor compliance, drug side effects and a sizable . . .

This publication has 9 references indexed in Scilit: